Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study
Haemophilia · 2024
DOI: 10.1111/hae.14965 ↗At a glance
Beobachtungsstudie in Haemophilia, 2024. Written by Fabian Tomschi and 11 co-authors. Institution: Department of Sports Medicine, University of Wuppertal, Wuppertal, Germany. Major MEDLINE topics: Hemophilia A. Cited 7 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Takeda Pharmaceutical Company.
Abstract (original language)
Introduction
Regular physical activity (PA) is recommended for patients with haemophilia (PwH). For PwH it is crucial to ensure a sufficient factor level to prevent PA‐induced bleedings. However, there is a gap in the literature dealing with specific factor levels, which are needed when performing specific types of PA.
Aim
To provide data on factor VIII (FVIII) levels at the start of PA performed by PwH.
Methods
In this prospective 12‐month real‐world observational study, 23 PwH recorded every PA they performed and the FVIII levels at the start of the PA using a pharmacokinetic application. PA types were clustered according to the collision and injury risk into three categories (Cat I = low, Cat II = medium, Cat III = high risk). Haemophilia Joint Health Scores (HJHS) were performed at baseline, after 6 and 12 months.
Results
795 PA sessions of Cat I, 193 of Cat II, and 23 of Cat III were documented. FVIII levels at the start of PA were different between categories (Cat I: 29.8 ± 32.1%, Cat II: 38.3 ± 33.4%, Cat III: 86.6 ± 29.2%). Out of all PA sessions, 145 (14%) were performed at a factor level of ≤3%. Three PA‐induced bleeding occurred. Baseline HJHS was 14.5 ± 13.6 points and did not change throughout the study.
Conclusion
This study provides real‐life data on FVIII levels at the start of 1011 PA sessions. PwH are mainly active in low‐risk sports with higher FVIII levels observed in Cat II and III, respectively. Only three PA‐induced bleeding occurred, even though several PA were started with low FVIII levels.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Sports Medicine, University of Wuppertal, Wuppertal, Germany.
- Institute for Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany.
- Department of Orthopaedics and Trauma Surgery, University of Bonn, Bonn, Germany.
- Haemophilia Centre Muenster, Muenster, Germany.
ORCID profiles: Fabian Tomschi, Jamil Hmida, Pia Ransmann, Alexander Schmidt, Andreas C Strauß, Johannes Oldenburg, Thomas Hilberg
Funding
- Takeda Pharmaceutical Company
Cite
APA
Tomschi, F., Hmida, J., Herzig, S., Ransmann, P., Brühl, M., Schmidt, A., Herzig, M., Goldmann, G., Strauß, A. C., Oldenburg, J., Richter, H., & Hilberg, T. (2024). Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study. Haemophilia. https://doi.org/10.1111/hae.14965
Vancouver
Tomschi F, Hmida J, Herzig S, Ransmann P, Brühl M, Schmidt A, et al. Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study. Haemophilia. 2024. doi:10.1111/hae.14965
BibTeX
@article{Tomschi2024,
author = {Tomschi, Fabian and Hmida, Jamil and Herzig, Steffen and Ransmann, Pia and Brühl, Marius and Schmidt, Alexander and Herzig, Marie and Goldmann, Georg and Strauß, Andreas C and Oldenburg, Johannes and Richter, Heinrich and Hilberg, Thomas},
title = {Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study},
journal = {Haemophilia},
year = {2024},
doi = {10.1111/hae.14965}
}
EUVIMED